JP2008526893A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526893A5
JP2008526893A5 JP2007550575A JP2007550575A JP2008526893A5 JP 2008526893 A5 JP2008526893 A5 JP 2008526893A5 JP 2007550575 A JP2007550575 A JP 2007550575A JP 2007550575 A JP2007550575 A JP 2007550575A JP 2008526893 A5 JP2008526893 A5 JP 2008526893A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
inhalable
inhalable pharmaceutical
patient
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007550575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526893A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/000910 external-priority patent/WO2006086107A2/en
Publication of JP2008526893A publication Critical patent/JP2008526893A/ja
Publication of JP2008526893A5 publication Critical patent/JP2008526893A5/ja
Withdrawn legal-status Critical Current

Links

JP2007550575A 2005-01-10 2006-01-10 肺における吸入可能なインスリンの自然増加を最少化するための方法及び組成物 Withdrawn JP2008526893A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64305405P 2005-01-10 2005-01-10
PCT/US2006/000910 WO2006086107A2 (en) 2005-01-10 2006-01-10 Methods and compositions for minimizing accrual of inhalable insulin in the lungs

Publications (2)

Publication Number Publication Date
JP2008526893A JP2008526893A (ja) 2008-07-24
JP2008526893A5 true JP2008526893A5 (https=) 2009-03-05

Family

ID=36793549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550575A Withdrawn JP2008526893A (ja) 2005-01-10 2006-01-10 肺における吸入可能なインスリンの自然増加を最少化するための方法及び組成物

Country Status (7)

Country Link
US (1) US20060153778A1 (https=)
EP (1) EP1858486A2 (https=)
JP (1) JP2008526893A (https=)
AU (1) AU2006213084A1 (https=)
CA (1) CA2592776A1 (https=)
MX (1) MX2007008379A (https=)
WO (1) WO2006086107A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
DK1808438T3 (da) 1999-06-29 2014-10-27 Mannkind Corp Rensning og stabilisering af peptid og proteiner i lægemidler
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
US9078866B2 (en) * 2003-08-01 2015-07-14 Mannkind Corporation Method for treating hyperglycemia with GLP-1
US20070027063A1 (en) * 2004-01-12 2007-02-01 Mannkind Corporation Method of preserving the function of insulin-producing cells
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
AU2014271222B2 (en) * 2005-09-14 2016-04-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
IN2015DN00888A (https=) 2006-02-22 2015-07-10 Mannkind Corp
JP2011500850A (ja) * 2007-10-24 2011-01-06 マンカインド コーポレイション Glp−1による副作用を防止する方法
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
US20190262557A1 (en) * 2010-03-04 2019-08-29 Mannkind Corporation Dry powder drug delivery system
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US11110151B2 (en) * 2008-08-11 2021-09-07 Mannkind Corporation Composition and method for reducing hypoglycemia events in diabetes treatment
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
AU2014200960B2 (en) * 2009-03-04 2016-02-11 Mannkind Corporation An improved dry powder drug delivery system
MX2011009251A (es) * 2009-03-04 2011-11-18 Mannkind Corp Sistema mejorado de suministro de farmaco en polvo seco.
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
EP3556356B1 (en) * 2009-06-12 2021-05-05 MannKind Corporation Diketopiperazine microparticles with defined isomer content
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2000301A (en) * 1932-04-02 1935-05-07 Norman Confections Inc Progressive container
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
DK1808438T3 (da) * 1999-06-29 2014-10-27 Mannkind Corp Rensning og stabilisering af peptid og proteiner i lægemidler
NZ548980A (en) * 2004-01-12 2009-10-30 Mannkind Corp Reducing serum proinsulin levels in type 2 diabetics

Similar Documents

Publication Publication Date Title
JP2008526893A5 (https=)
Nishimura High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects
Shankar et al. Isoflurane therapy for severe refractory status asthmaticus in children
Diaz et al. Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis
JP2008534622A5 (https=)
MX2023001592A (es) Inhalador de polvo seco.
JP2015110631A5 (https=)
JP2011500850A5 (https=)
JP2010522212A5 (https=)
YU36302A (sh) Novi tiotropiumski preparati - koji sadrže prah za inhaliranje
Morán et al. Heat and moisture exchangers and heated humidifiers in acute lung injury/acute respiratory distress syndrome patients. Effects on respiratory mechanics and gas exchange
AR067639A1 (es) Medicamentos pulverulentos que contienen tiotropio y salmetrol, asi como lactosa como excipiente
WO2006059108A3 (en) ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES
UA101653C2 (uk) Композиція для інгаляції, що містить аклідиній для лікування астми та хронічного обструктивного захворювання легень
MXPA03011861A (es) Particulas para inhalacion que tienen rapidas propiedades de liberacion.
UA101652C2 (uk) Композиція для інгаляції, що містить аклідиній для лікування астми та хронічного обструктивного захворювання легень
JP2007520506A5 (https=)
JP2007520507A5 (https=)
Eden et al. Prolonged smoldering Douglas fir smoke inhalation augments respiratory resistances, stiffens the aorta, and curbs ejection fraction in hypercholesterolemic mice
JP2023523557A5 (https=)
Brain Unlocking the opportunity of tight glycaemic control: Inhaled insulin: safety
CN102133319B (zh) 一种平喘止咳的药物及其制备方法
WO2005041922A3 (en) Composition
BR0316343A (pt) Formulações pulverulentas para inalação contendo tiotrópio
DE60308497D1 (de) Pulverzubereitungen zur inhalation